pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4486 |
Genomic Coordinates | chr11: 19575310 - 19575372 |
Description | Homo sapiens miR-4486 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4486 | ||||||||||||
Sequence | 5| GCUGGGCGAGGCUGGCA |21 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TBCCD1 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | TBCC domain containing 1 | ||||||||||||||||||||
Transcript | NM_001134415 | ||||||||||||||||||||
Other Transcripts | NM_018138 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TBCCD1 | |||||||||||||||||||||
3'UTR of TBCCD1 (miRNA target sites are highlighted) |
>TBCCD1|NM_001134415|3'UTR 1 GGATCTTACATGCAGACACTGGGCCCTGGAAATACAAGGATAAATGGAGGATGGTGCTCATCTTGAAACTTGAAACTAAA 81 TTGGGAAGGTGCTATTGCTGCTTAAGAGACATTGGGACTTTTCTGTCTTTTTTTTTTTTTTTTTTTGAGGCAGAGTCTTG 161 TTCTGTCGCCCAGGCTGGAGTGCAGTGGCGCGATCTCGGCTCACTGCAAGCTCTGCCTCCCGGGTTCACGCCATTCTCCT 241 GCCTCAGCCTCCTGAGTAGCTGGGACTACAGGCGCCCGCCACCACGCCCGGCCAATTTTTTTTGTATTTTTAGTAGAGAC 321 GGGGTTTCACCGTGTTAGTCAGGATGGTCTCGATTTCCTGACCTCGTGATCCGCCCATCTCGGCCTCCCAAAGTGCTGGG 401 ATTACAGGCGTGAGCCACCGTGCCCAGCCTTCTGTTCTATTTAAGAACTTTGATTTCCATTCCATTTTCATTTATTACTG 481 TTTAGGCCGAATTTTCGCTAAACTTCTGACTTTCATATAAACATATTGCTTATAGAACATCAGAAGACTCGTCTTTGTGA 561 TGCCCAAATGAAAAAGTTGGTGAAGGTAGTACCATTGTATGTATGTTAATATTAAAGCAACTGAGTGTAGATTTGCAACT 641 ATAGTGTGTATCTTCATTTGTGTGATGAAAGAGTTTTATTCTTTCTAGAGTTAAATAAGAGTTTTATAGTTCTTTGTAAC 721 TATTTAAAAGGAAATTGCTACTCCTTTTAAAAAATAATTGGAAAGGAAGTATGATTTGTTGGTATATAGACATAGAAATA 801 GTTTTATACTATATTTTAGTCCTTAAAGTATGGAACTTAATGAAATTGTTTAAAAAAATCTTTATTTTTCACTTCCTGCT 881 TCAAATTTTCAATAAACAAACTCTAAAGAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 55171.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714646. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Prostate Tissue | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760631. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_B
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_001134415 | 3UTR | GUUCUGUCGCCCAGGCUGGAGUGCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001134415 | 3UTR | CCCAGGCUGGAGUGCAGUGGCGCGAUCUCGGCUCACUGCAAGCUCUGCCUCCCGGGUUCACGCCAUUCUCCUGCCUCAGCCUCCUGAGUAGCUGGGACUACAGGCGCCCGCCACCACGCCCGGCCAAUUUUUUUUGUAUUUUUAGUAGAGACGGGGUUUCACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_018138 | 3UTR | UGUUCUGUCGCCCAGGCUGGAGUGCAGUGGCGCGAUCUCGGCUCACUGCAAGCUCUGCCUCCCGGGUUCACGCCAUUCUCCUGCCUCAGCCUCCUGAGUAGCUGGGACUACAGGCGCCCGCCACCACGCCCGGCCAAUUUUUUUUGUAUUUUUAGUAGAGACGGGGUUUCACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001134415 | 3UTR | UCUUGUUCUGUCGCCCAGGCUGGAGUGCAGUGGCGCGAUCUCGGCUCACUGCAAGCUCUGCCUCCCGGGUUCACGCCAUUCUCCUGCCUCAGCCUCCUGAGUAGCUGGGACUACAGGCGCCCGCCACCACGCCCGGCCAAUUUUUUUUGUAUUUUUAGUAGAGACGGGGUUUCACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_018138 | 3UTR | UGUUCUGUCGCCCAGGCUGGAGUGCAGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_018138 | 3UTR | UUGUUCUGUCGCCCAGGCUGGAGUGCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001134415 | 3UTR | AGUCUUGUUCUGUCGCCCAGGCUGGAGUGCAGUGGCGCGAUCUCGGCUCACUGCAAGCUCUGCCUCCCGGGUUCACGCCAUUCUCCUGCCUCAGCCUCCUGAGUAGCUGGGACUACAGGCGCCCGCCACCACGCCCGGCCAAUUUUUUUUGUAUUUUUAGUAGAGACGGGGUUUCACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM714646 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repA |
Location of target site | ENST00000424280.1 | 3UTR | CAGAGUCUUGUUCUGUCGCCCAGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
108 hsa-miR-4486 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT254654 | NF2 | neurofibromin 2 | 2 | 2 | ||||||||
MIRT458684 | MRI1 | methylthioribose-1-phosphate isomerase 1 | 2 | 2 | ||||||||
MIRT470845 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT493011 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT497264 | GRK6 | G protein-coupled receptor kinase 6 | 2 | 2 | ||||||||
MIRT497675 | SYNGR1 | synaptogyrin 1 | 2 | 2 | ||||||||
MIRT498219 | TLN2 | talin 2 | 2 | 2 | ||||||||
MIRT498310 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT504048 | TOMM5 | translocase of outer mitochondrial membrane 5 | 2 | 2 | ||||||||
MIRT519959 | ZCCHC8 | zinc finger CCHC-type containing 8 | 2 | 2 | ||||||||
MIRT531521 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 2 | ||||||||
MIRT533144 | WNT10A | Wnt family member 10A | 2 | 2 | ||||||||
MIRT533541 | TPR | translocated promoter region, nuclear basket protein | 2 | 2 | ||||||||
MIRT533681 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT540321 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT540719 | GUF1 | GUF1 homolog, GTPase | 2 | 2 | ||||||||
MIRT541566 | ZNF43 | zinc finger protein 43 | 2 | 4 | ||||||||
MIRT541787 | TBCCD1 | TBCC domain containing 1 | 2 | 2 | ||||||||
MIRT541925 | ORC1 | origin recognition complex subunit 1 | 2 | 4 | ||||||||
MIRT542232 | FUT9 | fucosyltransferase 9 | 2 | 2 | ||||||||
MIRT542285 | POLR3K | RNA polymerase III subunit K | 2 | 2 | ||||||||
MIRT542299 | QTRTD1 | queuine tRNA-ribosyltransferase accessory subunit 2 | 2 | 4 | ||||||||
MIRT542368 | PAICS | phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase | 2 | 2 | ||||||||
MIRT542441 | C3 | complement C3 | 2 | 4 | ||||||||
MIRT542475 | APOC3 | apolipoprotein C3 | 2 | 2 | ||||||||
MIRT542535 | MRPS10 | mitochondrial ribosomal protein S10 | 2 | 2 | ||||||||
MIRT542640 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT542788 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT552104 | PPP1R1A | protein phosphatase 1 regulatory inhibitor subunit 1A | 2 | 2 | ||||||||
MIRT564913 | YTHDF1 | YTH N6-methyladenosine RNA binding protein 1 | 2 | 2 | ||||||||
MIRT568606 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT607389 | LANCL3 | LanC like 3 | 2 | 2 | ||||||||
MIRT607451 | ZNF543 | zinc finger protein 543 | 2 | 2 | ||||||||
MIRT610058 | MYBPC1 | myosin binding protein C, slow type | 2 | 2 | ||||||||
MIRT610793 | KLK2 | kallikrein related peptidase 2 | 2 | 2 | ||||||||
MIRT617176 | GOSR2 | golgi SNAP receptor complex member 2 | 2 | 2 | ||||||||
MIRT620579 | WBSCR27 | methyltransferase like 27 | 2 | 4 | ||||||||
MIRT622085 | SRPX2 | sushi repeat containing protein, X-linked 2 | 2 | 2 | ||||||||
MIRT622542 | PXMP4 | peroxisomal membrane protein 4 | 2 | 2 | ||||||||
MIRT630009 | PDE6B | phosphodiesterase 6B | 2 | 2 | ||||||||
MIRT631813 | PTDSS2 | phosphatidylserine synthase 2 | 2 | 2 | ||||||||
MIRT632721 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT632757 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT634821 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT635255 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT637082 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT637357 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT637472 | DEFB105B | defensin beta 105B | 2 | 4 | ||||||||
MIRT637504 | DEFB105A | defensin beta 105A | 2 | 4 | ||||||||
MIRT639022 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT641012 | ANKFY1 | ankyrin repeat and FYVE domain containing 1 | 2 | 2 | ||||||||
MIRT642170 | HEBP2 | heme binding protein 2 | 2 | 2 | ||||||||
MIRT648977 | ACAD8 | acyl-CoA dehydrogenase family member 8 | 2 | 2 | ||||||||
MIRT650515 | UFM1 | ubiquitin fold modifier 1 | 2 | 2 | ||||||||
MIRT650949 | INMT | indolethylamine N-methyltransferase | 2 | 2 | ||||||||
MIRT658354 | FAM65B | RHO family interacting cell polarization regulator 2 | 2 | 2 | ||||||||
MIRT660736 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT662191 | MEI1 | meiotic double-stranded break formation protein 1 | 2 | 2 | ||||||||
MIRT663045 | SLC16A4 | solute carrier family 16 member 4 | 2 | 2 | ||||||||
MIRT664811 | IRAK3 | interleukin 1 receptor associated kinase 3 | 2 | 2 | ||||||||
MIRT665161 | SF3A1 | splicing factor 3a subunit 1 | 2 | 4 | ||||||||
MIRT665346 | YES1 | YES proto-oncogene 1, Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT666493 | SBNO1 | strawberry notch homolog 1 | 2 | 2 | ||||||||
MIRT666545 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT669351 | BMP3 | bone morphogenetic protein 3 | 2 | 2 | ||||||||
MIRT669904 | KIAA0754 | KIAA0754 | 2 | 4 | ||||||||
MIRT670323 | CEP57L1 | centrosomal protein 57 like 1 | 2 | 2 | ||||||||
MIRT670430 | ELP2 | elongator acetyltransferase complex subunit 2 | 2 | 2 | ||||||||
MIRT670672 | KIAA1551 | KIAA1551 | 2 | 2 | ||||||||
MIRT670746 | HOOK3 | hook microtubule tethering protein 3 | 2 | 2 | ||||||||
MIRT670998 | PTGIS | prostaglandin I2 synthase | 2 | 2 | ||||||||
MIRT671290 | RPL37A | ribosomal protein L37a | 2 | 2 | ||||||||
MIRT671469 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | 2 | 2 | ||||||||
MIRT671833 | STIL | STIL, centriolar assembly protein | 2 | 2 | ||||||||
MIRT673006 | TAF1 | TATA-box binding protein associated factor 1 | 2 | 2 | ||||||||
MIRT675881 | CSTF1 | cleavage stimulation factor subunit 1 | 2 | 2 | ||||||||
MIRT678625 | OLFML2A | olfactomedin like 2A | 2 | 2 | ||||||||
MIRT678790 | NUPL2 | nucleoporin like 2 | 2 | 2 | ||||||||
MIRT679560 | LIN9 | lin-9 DREAM MuvB core complex component | 2 | 2 | ||||||||
MIRT681032 | AAED1 | AhpC/TSA antioxidant enzyme domain containing 1 | 2 | 2 | ||||||||
MIRT682480 | LIX1L | limb and CNS expressed 1 like | 2 | 2 | ||||||||
MIRT682758 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT682810 | TMCO1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT682867 | C9orf156 | tRNA methyltransferase O | 2 | 2 | ||||||||
MIRT689233 | RPS19 | ribosomal protein S19 | 2 | 2 | ||||||||
MIRT689305 | C5AR2 | complement component 5a receptor 2 | 2 | 2 | ||||||||
MIRT689363 | ZNF101 | zinc finger protein 101 | 2 | 2 | ||||||||
MIRT689629 | NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | 2 | 2 | ||||||||
MIRT689654 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT690148 | PPIL6 | peptidylprolyl isomerase like 6 | 2 | 2 | ||||||||
MIRT691407 | DNA2 | DNA replication helicase/nuclease 2 | 2 | 2 | ||||||||
MIRT691847 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 2 | 2 | ||||||||
MIRT692234 | ALDH1B1 | aldehyde dehydrogenase 1 family member B1 | 2 | 2 | ||||||||
MIRT694320 | NLRP9 | NLR family pyrin domain containing 9 | 2 | 2 | ||||||||
MIRT694365 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT696215 | LYZ | lysozyme | 2 | 2 | ||||||||
MIRT697230 | ZYG11A | zyg-11 family member A, cell cycle regulator | 2 | 2 | ||||||||
MIRT700487 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT700612 | PRKCA | protein kinase C alpha | 2 | 2 | ||||||||
MIRT702456 | KIAA1467 | family with sequence similarity 234 member B | 2 | 2 | ||||||||
MIRT702990 | HERPUD2 | HERPUD family member 2 | 2 | 2 | ||||||||
MIRT703998 | EIF5A2 | eukaryotic translation initiation factor 5A2 | 2 | 2 | ||||||||
MIRT704701 | CHRFAM7A | CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion | 2 | 2 | ||||||||
MIRT712481 | FSTL3 | follistatin like 3 | 2 | 2 | ||||||||
MIRT712781 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT714369 | HP1BP3 | heterochromatin protein 1 binding protein 3 | 2 | 2 | ||||||||
MIRT722570 | C1orf95 | stum, mechanosensory transduction mediator homolog | 2 | 2 | ||||||||
MIRT722839 | C17orf102 | chromosome 17 open reading frame 102 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|